IDENTIFICATION AND ASSESSMENT OF TARGETS FOR IMMUNOTHERAPY IN NF2-ASSOCIATED SCHWANNOMATOSIS
$968,875FY2025Defense Health AgencyDOD
H. Lee Moffitt Cancer Center And Research Institute Hospital, Inc.
H. Lee Moffitt Cancer Center And Research Institute Hospital, Inc.